Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Halozyme Therapeutics
Pharma
Arbitrator sides with J&J, upholding Darzalex ruling vs. Genmab
An appeal arbitrator has rejected Genmab’s claim that it is due additional milestone and royalty payments from Johnson & Johnson for Darzalex.
Kevin Dunleavy
Jan 23, 2024 10:23am
BMS's subcutaneous Opdivo measures up to infused version
Oct 19, 2023 11:10am
Roche scores with subcutaneous version of MS drug Ocrevus
Jul 13, 2023 10:18am
Halozyme beefs up drug delivery franchise with $1B deal
Apr 13, 2022 10:55am
FDA oncology chief, Senate bill, Insilico—Fierce Pharma Asia
Apr 1, 2022 9:35am
Roche's Chugai pays $25M to access subcutaneous delivery tech
Mar 29, 2022 8:05am